UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_________________

FORM 10-Q

_________________

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2020 

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

_________________

GENESYS INDUSTRIES, INC.

_________________

 

Florida 333-213387 30-0852686
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation or Organization) File Number) Identification No.)

1914 24th Ave E Palmetto, Florida 34221
(Address of Principal Executive Offices) (Zip Code)

941-722-3600
(Registrant’s telephone number, including area code)

_________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒  No ☐ 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☒ Smaller reporting company ☒
Emerging growth company ☒  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes ☐  No ☒

APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:  As of May 12, 2020, the issuer had 18,250,000 shares of its common stock issued and outstanding. 

  1  

 

 

TABLE OF CONTENTS

PART I    
Item 1. Condensed Unaudited Consolidated Financial Statements 4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
Item 3. Quantitative and Qualitative Disclosures About Market Risk 16
Item 4. Controls and Procedures 16
PART II    
Item 1. Legal Proceedings 17
Item 1A. Risk Factors 17
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 17
Item 3. Defaults Upon Senior Securities 17
Item 4. Mining Safety Disclosures 17
Item 5. Other Information 17
Item 6. Exhibits 17
  Signatures 18

  2  

 

 

 PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

GENESYS INDUSTRIES, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

MARCH 31, 2020

 

Condensed Consolidated Balance Sheets as of December 31, 2019 and June 30, 2019 (Unaudited) 4
Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2019 and 2018 (Unaudited) 5
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the three and six months ended December 31, 2019 and 2018 (Unaudited) 6
Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2019 and 2018 (Unaudited) 7
Notes to the Condensed Consolidated Financial Statements (Unaudited) 8

  

  3  

 

 

GENESYS INDUSTRIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 
     

March 31,

2020

     

June 30,

2019

 
ASSETS     (Unaudited)          
Current assets:                
Cash   $ 210,099     $ 170,205  
Accounts receivable     87,181       52,811  
Prepaid     12,611       —    
Inventory     7,647       —    
Total current assets     317,538       223,016  
Machinery and equipment, net     350,182       163,028  
Real property & plant, net     229,759       239,377  
Total Assets   $ 897,479     $ 625,421  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                
Current liabilities:                
Accounts payable and accrued liabilities   $ 39,623     $ 25,137  
Accrued interest, related party     9,749       5,463  
Accrued compensation     6,216       3,642  
Line of credit – current portion     37,081       42,071  
Loans payable– current portion     45,644       24,329  
Convertible note payable, net of discount of $87,500     62,500       —    
Due to related party     122,729       102,129  
Income tax accrual     —         38,484  
Total current liabilities     323,542       241,255  
Long term liabilities:                
Line of credit     79,776       101,192  
Loans payable     268,665       184,556  
Total liabilities     671,983       527,003  
                 
Commitments and contingencies     —         —    
                 
Stockholders' equity (deficit):                
Class B Preferred stock, $0.001 par value, 25,000,000 shares authorized, 10,000,000 and 10,000,000 issued and outstanding, respectively     10,000       10,000  
Common stock, $0.001 par value, 100,000,000 shares authorized; 18,100,000 and 17,870,000 shares issued and outstanding, respectively     18,100       17,870  
Common stock to be issued     16,500       —    
Additional paid-in capital     383,900       101,130  
Accumulated deficit     (203,004 )     (30,582 )
Total stockholders' equity     225,496       98,418  
Total Liabilities and Stockholders' Equity   $ 897,479     $ 625,421  

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

  4  

 

 

GENESYS INDUSTRIES, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

 
    For the Three Months Ended March 31,   For the Nine Months Ended March 31,
    2020   2019   2020   2019
Revenue   $ 163,782     $ 188,070     $ 438,656     $ 621,515  
Cost of revenue     98,058       127,869       266,862       363,523  
Gross Margin     65,724       60,201       171,794       257,992  
Operating Expenses:                                
Professional fees     10,100       10,200       29,905       20,800  
Payroll expense     23,771       10,753       52,551       32,173  
General & administrative expenses     23,556       25,902       63,034       64,262  
Total operating expenses     57,427       46,855       145,490       117,235  
                                 
Income (loss) from operations     8,297       13,346       (26,304 )     140,757  
                                 
Other expense:                                
Interest expense     (6,329 )     (4,411 )     (21,226 )     (18,191 )
Debt discount amortization     (62,500 )     —         (62,500 )     —    
Loss on issuance of common stock     —         —         (40,000 )     —    
Loss on issuance of convertible debt     (75,000 )     —         (75,000 )     —    
Total other expense     (143,829 )     (4,411 )     (198,726 )     (18,191 )
                                 
Income (loss) before income taxes     (135,532 )     8,935       (172,422 )     122,566  
Provision for income taxes     —         (7,438 )     —         (33,400 )
                                 
Net Income (Loss)   $ (135,532 )   $ 1,497     $ (172,422 )   $ 89,166  
                                 
Net Income (Loss) Per Common Share, basic & diluted   $ (0.01 )   $ 0.00     $ (0.01 )   $ 0.00  
Weighted Common Shares Outstanding, basic & diluted     18,100,000       17,870,000       18,011,309       17,870,000  

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

  5  

 

 

GENESYS INDUSTRIES, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

(Unaudited)

 

For the Nine Months Ended March 31, 2019
 
      Common Shares       Common Stock      

Preferred

Shares

      Preferred       Paid in Capital       Accumulated Deficit       Total   
Balance, June 30, 2018     17,870,000     $ 17,870       10,000,000     $ 10,000     $ 101,130     $ (133,325 )   $ (4,325 )
Net income     —         —         —         —         —         22,607       22,607  
Balance, September 30, 2018     17,870,000       17,870       10,000,000       10,000       101,130       (110,718 )     18,282  
Net income     —         —         —         —         —         65,062       65,062  
Balance, December 31, 2018     17,870,000     $ 17,870       10,000,000     $ 10,000     $ 101,130     $ (45,656 )   $ 83,344  
Net income     —         —         —         —         —         1,497       1,497  
Balance, March 31, 2019     17,870,000     $ 17,870       10,000,000     $ 10,000     $ 101,130     $ (44,159 )   $ 84,841  

 

For the Nine Months Ended March 31, 2020
 
      Common Shares       Common Stock      

Preferred

Shares

      Preferred       Common Stock to be Issued       Paid in Capital       Accumulated Deficit       Total       
Balance, June 30, 2019     17,870,000     $ 17,870       10,000,000     $ 10,000     $ —       $ 101,130     $ (30,582 )   $ 98,418  
Common stock issued for services     130,000       130       —         —         —         12,870       —         13,000  
Net income     —         —         —         —         —         —         7,481       7,481  
Balance, September 30, 2019     18,000,000       18,000       10,000,000       10,000       —         114,000       (23,101 )     118,899  
Common stock issued for services     100,000       100       —         —         —         69,900       —         70,000  
Net income     —         —         —         —         —         —         (44,371 )     (44,371 )
Balance, December 31, 2019     18,100,000       18,100       10,000,000       10,000       —         183,900       (67,472 )     144,528  
Common stock issued for services     —         —         —         —         16,500       —         —         16,500  
Beneficial conversion feature     —         —         —         —         —         200,000       —         200,000  
Net loss             —         —         —         —         —         (135,532 )     (135,532 )
Balance, March 31, 2020     18,100,000     $ 18,100       10,000,000     $ 10,000     $ 16,500     $ 283,900     $ (203,004 )   $ 225,496  

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

  6  

 

 

GENESYS INDUSTRIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 
    For the Nine Months Ended
March 31,
    2020   2019
Cash flows from operating activities:                
Net (Loss) Income   $ (172,422 )   $ 89,166  
Adjustments to reconcile net loss to net cash used in operating activities:                
Amortization expense     —         —    
Depreciation expense     49,553       30,056  
Provision for income taxes     (38,484 )     —    
Stock compensation expense     46,889       —    
Loss on issuance of common stock     40,000       —    
Loss on issuance of convertible debt     75,000       —    
Debt discount amortization     62,500       —    
Changes in operating assets and liabilities:                
Accounts receivable     (34,370 )     42,445  
Inventory     (7,647 )     (1,757 )
Accounts payable and accruals     18,773       20,514  
Accrued interest, related party     2,574       2,494  
Net cash provided by operating activities     42,366       182,918  
                 
Cash flows from investing activities:                
Purchase of property and equipment     (227,090 )     —    
Net cash used in investing activities     (227,090 )     —    
                 
Cash flows from financing activities:                
Advances / payments - related party     20,600       (1,388 )
Proceeds from loan payable     145,147       —    
Proceeds from convertible debt     125,000       —    
Payments on line of credit     (26,406 )     (25,336 )
Principal payment on mortgage     (7,671 )     (6,035 )
Principal payment on loan payable     (32,053 )     (3,640 )
Net cash provided (used) by financing activities     224,617       (36,399 )
                 
Net increase in cash     39,893       146,519  
                 
Cash, beginning of period     170,206       17,866  
Cash, end of period   $ 210,099     $ 164,385  
                 
Supplemental disclosure of cash flow information:                
Cash paid for interest   $ 16,389     $ 14,237  
Cash paid for taxes   $ —       $ —    

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

  7  

 

 

GENESYS INDUSTRIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2020

(Unaudited)

 

 

NOTE 1 - NATURE OF OPERATIONS

 

Genesys Industries, Inc. (the “Company”), was incorporated on December 9, 2014 under the laws of the State of Florida. Genesys Industries is a diversified multi-industry manufacturer of complex metal components and products. We serve all general industrial markets such as Aerospace, Automotive, Commercial, Food Processing, Industrial, Maritime, Medical, Railroad, Oil and Gas, Packaging, Telecom, Textiles, Robotics, Space Travel, Transportation and many more. We are a vertically integrated precision CNC manufacturing and fabrication company with core emphasis on product design, engineering and precision manufacturing of complex components and products.

 

On February 5, 2018, the Company formed Genesys Industries, LLC as a wholly owned subsidiary in the state of Missouri.

 

The Company’s headquarters are in Palmetto, Florida. The Company has adopted its fiscal year end to be June 30.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at March 31, 2020 and for the related periods presented have been made. The results for the nine months ended March 31, 2020 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2020, filed with the Securities and Exchange Commission

 

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Significant estimates include the estimated useful lives of property and equipment.  Actual results could differ from those estimates.

 

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Genesys Industries, LLC, and been prepared in conformity with accounting principles generally accepted in the United States of America. All significant intercompany transactions and balances have been eliminated.

 

Reclassifications

Certain reclassifications have been made to the prior period financial information to conform to the presentation used in the financial statements for the three and nine months ended March 31, 2020.

 

Inventories

Inventories are valued at the lower of cost or market. Management compares the cost of inventories with the market value and allowance is made for writing down their inventories to market value, if lower.

 

Property, Plant and Equipment

Property and equipment are carried at the lower of cost or net realizable value. Major betterments that extend the useful lives of assets are also capitalized. Normal maintenance and repairs are charged to expense as incurred. When assets are sold or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in operations.

 

Website development

Website development is carried at cost. Major betterments that would extend the useful life are capitalized. Normal maintenance and repairs are charged to expense as incurred. When assets are sold or otherwise disposed of, the cost and accumulated amortization are removed from the accounts and any resulting gain or loss is recognized in operations. Website development costs are being amortized on a straight-line basis over three years.

 

  8  

 

 

Accounts Receivable

Revenues that have been recognized but not yet received are recorded as accounts receivable. Losses on receivables will be recognized when it is more likely than not that a receivable will not be collected. An allowance for estimated uncollectible amounts will be recognized to reduce the amount of receivables to its net realizable value. The allowance for uncollectible amounts is evaluated quarterly.

 

Revenue Recognition

Revenue is recognized goods are shipped or services performed and is recognized in an amount that reflects the consideration that an entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods. The Company applies the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.

 

The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The company recognizes revenue when all performance obligations are completed, and the risk of loss is transferred to the customer upon shipment.

 

During the nine months ended March 31, 2020, the Company recognized $273,803 and $79,090 of sales from its two largest customers, representing 62.5%, and 18%, respectively, of total sales.

 

During the nine months ended March 31, 2019, the Company recognized $195,631, $136,858, and $129,436 from its three largest customers, representing 31%, 22% and 21% of total sales, respectively.

 

Right of Return

From time to time, the company in the normal course of business encounters product returns.  The company policy is to identify the reason of return and to either replace product, rework product or cancel the order at the request of the customer. As of March 31, 2020, and June 30, 2019, there were no substantial claims for rework or replacement in the normal course of business.

 

Recently issued accounting pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 - GOING CONCERN

 

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.  As reflected in the unaudited accompanying consolidated financial statements, the Company has experienced a significant increase in revenue since commencing it operations in 2018. As of March 31, 2020, the Company has an accumulated deficit of $203,004 and for the nine months ended March 31, 2020. We had a net loss of $172,422 and received cash from operations of $42,366. For the nine months ended March 31, 2020, a portion of our net loss consisted of $177,500 of non-cash expense related to the issuance of stock and convertible debt. Although the Company’s financial position is steadily improving our operations are still relatively new, circumstances may still occur that would raise substantial doubt about the Company’s ability to continue as a going concern.

 

While the Company is successfully executing its growth strategy, its cash position may not still be sufficient to support the Company’s daily operations without additional financing. While the Company believes in the viability of its strategy to produce sales volume and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenues. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern.

 

  9  

 

 

NOTE 4 – PROPERTY, PLANT & EQUIPMENT

 

Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.

 

Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets between three and five years. Leasehold improvements are being depreciated over ten years, and the building over twenty years.

 

Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income.

 

Intangible assets stated at cost, less accumulated amortization consisted of the following:

 

    March 31, 2020   June 30, 2019
Website development   $ 1,850     $ 1,850  
Less: accumulated amortization     (1,850 )     (1,850 )
Website development, net   $ —       $ —    

 

Amortization expense

Amortization expense for the nine months ended March 31, 2020 and 2019 was $0 and $0, respectively.

 

Property, Plant and equipment stated at cost, less accumulated depreciation consisted of the following:   

             

    March 31, 2020   June 30, 2019
Leasehold Improvements   $ 86,820     $ 62,261  
Machinery and Equipment     334,482       136,365  
Furniture     4,414       —    
Real Property & Plant     256,443       256,443  
Less: accumulated depreciation     (102,218 )     (52,664 )
Fixed assets, net   $ 579,941     $ 402,405  

 

Depreciation expense

 

Depreciation expense for the nine months ended March 31, 2020 and 2019 was $49,553 and $30,056, respectively.

 

NOTE 5 – LINES OF CREDIT

 

The Company has established a line of credit with a commercial bank in the amount of $50,000. This is a revolving business line of credit (BLOC) and bears a fixed interest rate of 7%. The company has also established a corporate business credit card for use in travel related purposes. That line of credit is established at $20,000. The company has also established a renewable Bank Term Loan Facility in the approximate amount of $200,000 with a fixed interest rate of 5%.

 

Total consolidated revolving credit available under all credit arrangements is approximately $270,000. On March 9, 2018, the Company obtained a $180,000 loan against the bank term loan. The loan has a term of five years and required interest only payments of $600 until May 26, 2018, thereafter payments of principal and interest of $3,396.82. As of March 31, 2020 and June 30, 2019, the balance on the loan is $116,857 and $143,263, respectively.

 

  10  

 

 

Future minimum payments of principal and interest for the fiscal years ended are as follows:

 

Fiscal Year   Amount
2020   $ 10,518  
2021     42,071  
2022     42,071  
2023     31,150  
Total   $ 125,810  

 

NOTE 6 – LOAN PAYABLE

 

On February 28, 2018, the Company purchased certain real property and approximately 2 acres of land in Missouri. The total acquisition cost including all closing costs and fees was $256,443. The purchase price was partially financed with a $200,000 loan from the company’s primary bank. The loan has a term of 5-years, at an interest rate of 4.09% and requires monthly payments of interest and principal of $1,494.59 with a final payment of approximately $148,063 due March 1, 2023. As March 31, 2020, and June 30, 2019, the balance on the loan is $178,985 and $186,655, respectively.

 

Future minimum payments of principal and interest for the fiscal years ended are as follows:

 

Fiscal Year   Amount
2020   $ 2,989  
2021     17,935  
2022     17,935  
2023     17,935  
2024     140,996  
Total   $ 197,790  

 

In April 2018 the Company purchased equipment to be used in their operations for a total acquisition price of $32,792. The equipment was purchased with a combination of cash and loan financing. The Company obtained a loan for $27,500 from their primary bank. The loan, dated May 7, 2018, matures on May 7, 2023, bears interest at 6% per annum and requires monthly payments of interest and principal of $532.84. During the quarter ended December 31, 2019, this loan was repaid in full. As of March 31, 2020 and June 30, 2019, the balance on the loan is $0 and $22,230, respectively.

 

In September 2019 the Company purchased equipment to be used in their operations for a total acquisition price of $87,000. The equipment was purchased with a combination of cash and loan financing. The Company obtained a loan for $70,147. The loan, dated August 12, 2019, matures on August 12, 2024, bears interest at 6.6% per annum and requires monthly payments of interest and principal of $1,379.09. As of March 31, 2020 the balance on the loan is $63,117.

 

Future minimum payments of principal and interest for the fiscal years ended are as follows:

 

Fiscal Year   Amount
2020   $ 4,137  
2021     16,549  
2022     16,549  
2023     7,232  
Total   $ 44,467  

 

On December 18, 2019, the Company received a $38,000 loan disbursement from American Express. The loan bears interest at 8.98% per annum, is to be paid in full by December 23, 2022 and requires monthly payments of interest and principal of $1,208.23. As of March 31, 2020 the balance on the loan is $35,207.

 

Future minimum payments of principal and interest for the fiscal years ended are as follows:

 

Fiscal Year   Amount
2020   $ 3,625  
2021     14,499  
2022     14,499  
2023     7,240  
Total   $ 39,863  

 

  11  

 

 

On March 27, 2020, the Company received a $37,000 loan disbursement from American Express. The loan bears interest at 8.98% per annum, is to be paid in full by April 1, 2023 and requires monthly payments of interest and principal of $1,176.43. As of March 31, 2020 the balance on the loan is $37,000.

 

Future minimum payments of principal and interest for the fiscal years ended are as follows:

 

Fiscal Year   Amount
2020   $ 2,353  
2021     14,117  
2022     14,117  
2023     11,764  
Total   $ 42,351  

 

NOTE 7 – CONVERTIBLE DEBT

 

On January 2, 2020, the Company executed a 10% convertible promissory note in which it agreed to borrow up to $300,000. The note is convertible at a price per share equal to the lower of (a) the Fixed Conversion Price (which is fixed at a price equal to $0.30); or (b) 80% of the lowest trading price of the Company’s common stock during the 5 consecutive trading days prior to the date on which lender elects to convert all or part of the Note. The initial deposit of $125,000 was made on January 15, 2020 and included a $25,000 OID. As required by ASC 470-20-30-6 the company recognized and measured the embedded beneficial conversion feature at the commitment date of $200,000 which was credited to paid in capital, a $150,000 debt discount and a $75,000 loss on the issuance of convertible debt. As of March 31, 2020, $62,500 of the debt discount has been amortized to interest expense.

 

NOTE 8 - STOCKHOLDERS’ EQUITY

 

Common stock

 

Common stock includes 100,000,000 shares authorized at a par value of $0.001.

 

During the nine months ended March 31, 2020, the Company granted 130,000 shares of common stock for services to two individuals. The shares were valued at $0.10, for total non-cash expense of $13,000.

 

During the nine months ended March 31, 2020, the Company granted 100,000 shares of common stock for services. The shares were valued at $0.11, for total non-cash expense of $16,500. The expense is being amortized over the six-month term of the agreement; $3,889 of expense was recognized as of March 31, 2020. As of March 31, 2020, the shares have not yet been issued by the transfer agent and have been credited to common stock to be issued.

 

During the nine months ended March 31, 2020, the Company granted 100,000 shares of common stock for services valued at $30,000. The shares were valued at $0.70, the closing stock price on the date of grant, for total non-cash expense of $70,000. $40,000 of which was recorded as a loss on the issuance of common stock.

 

Preferred stock

 

Preferred stock includes 25,000,000 shares of authorized at a par value of $0.001. Preferred stock includes 25,000,000 shares of Class B authorized at a par value of $0.001. The Preferred Stock constitutes a convertible stock in which (1) one Preferred Share is convertible into (5) five Common Shares. The Preferred Stockholders are entitled to vote on any matters on which the common stock holders are entitled to vote.

 

NOTE 9 - RELATED PARTY TRANSACTIONS

 

On November 5, 2017, to fund its working capital requirements the Company obtained a Special Line of Credit (“LOC”) also recognized as a Blanket Secured Promissory Note for the total draw down amount of up to $500,000, from Twiga Capital Partners, LLC (“TCP”), an entity controlled by the Company’s sole officer and largest stockholder, Shefali Vibhakar. This Note is secured by all of the assets of the Company in accordance with the Security Agreement by and between the Company and the Holder dated as of November 5, 2017. The LOC bears interest at 5% per annum and is due on demand. As of March 31, 2020 and June 30, 2019, the Company owed $122,729 and $102,129 of principal and $9,749 and $5,463 of accrued interest on the LOC, respectively.

  

NOTE 10 - SUBSEQUENT EVENTS

 

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

 

  12  

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our unaudited financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.

 

Forward Looking Statements

 

Certain matters discussed herein are forward-looking statements. Such forward-looking statements contained in this Form 10-Q involve risks and uncertainties, including statements as to:

 

• our future operating results;
• our business prospects;
• our contractual arrangements and relationships with third parties;
• the dependence of our future success on the general economy;
• our possible future financings; and
• the adequacy of our cash resources and working capital.

These forward-looking statements can generally be identified as such because the context of the statement will include words such as we “believe,” “anticipate,” “expect,” “estimate” or words of similar meaning. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which are described in close proximity to such statements and which could cause actual results to differ materially from those anticipated. Shareholders, potential investors and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included herein are only made as of the date of this Form 10-Q, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

 

Cautionary Statement:

 

Statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, in future filings by the Company with the Securities and Exchange Commission, in the Company’s press releases and in oral statements made with the approval of an authorized executive officer that are not historical or current facts are “forward-looking statements.” These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. These risks and uncertainties are described in the Company’s Annual Report on Form 10-K for the year ended June 30, 2019, as well as other filings the Company makes with the Securities and Exchange Commission. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made and are not predictions of actual future results. The Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

 

Plan of Operations

 

Genesys Industries is a diversified multi-industry manufacturer of complex metal components and products. We serve all general industrial markets such as Aerospace, Automotive, Construction, Commercial, Food Processing, Industrial, Maritime, Medical, Railroad, Oil and Gas, Packaging, Telecom, Textiles, Pulp Paper, Transportation and many more. We are a vertically integrated precision cnc manufacturing and fabrication company with core emphasis on product design, engineering and precision manufacturing of complex components and products.

 

Results of Operation for the Three Months Ended March 31, 2020 and 2019

 

Revenues

For the three months ended March 31, 2020, we earned revenue of $163,782 compared to $188,070 for the three months ended March 31, 2019; a decrease of $24,288 or 12.9%. During the current fiscal year we ceased doing business with one of our former primary customers due to them becoming a credit risk.

 

  13  

 

 

Cost of Revenue

For the three months ended March 31, 2020, cost of revenue was $98,058, compared to $127,869 for the three months ended March 31, 2019; a decrease of $29,811 or 23.3%. Cost of revenue has decreased in conjunction with the decrease in revenue. Our cost of revenue consists of direct material, labor and overhead expenses.

 

Professional fees

Professional fees were $10,100 for the three months ended March 31, 2019 compared to $10,200 for the three months ended March 31, 2019; a decrease of only $100 or 1%. Professional fees consist of accounting, audit and legal fees.

 

Payroll expense

Payroll expense was $23,771 for the three months ended March 31, 2020 compared to $10,753 for the three months ended March 31, 2019, an increase of $13,018 or 121.1%. The increase can be attributed to an increase of our administrative staff.

 

General & administrative expenses

General & administrative expenses (“G&A”) were $23,556 for the three months ended March 31, 2020, compared to $25,902 for the three months ended March 31, 2019; a decrease of $2,346 or 9.1%.

  

Other expense

Other expense for the three months ended March 31, 2020 was $143,829. Other expense consisted of $6,329 of interest expense, and $62,500 of debt discount amortization and a $75,000 loss on the issuance of convertible debt as a result of the issuance of a new convertible promissory note. For the three months ended March 31, 2019 we had $4,411 of interest expense.

 

Net Loss

Net loss for the three months ended March 31, 2020 was $135,532 compared to net income of $1,497, after a $7,438 provision for income taxes, for the three months ended March 31, 2019. The change from net income in the prior period to a net loss in the current period can be attributed to the loss of one of our larger customers as well as our non-cash expense for stock compensation and the issuance of a convertible note.

 

Results of Operation for the Nine Months Ended March 31, 2020 and 2019

 

Revenues

For the nine months ended March 31, 2020, we earned revenue of $438,656 compared to $621,515 for the nine months ended March 31, 2019; a decrease of $182,859 or 29.4%. During the current period we ceased doing business with one of our former primary customers due to them becoming a credit risk.

 

Cost of Revenue

For the nine months ended March 31, 2020, cost of revenue was $266,862, compared to $363,523 for the nine months ended March 31, 2019; a decrease of $96,661 or 26.6%. Cost of revenue has decreased in conjunction with the decrease in revenue. Our cost of revenue consists of direct material, labor and overhead expenses.

 

Professional fees

Professional fees were $29,905 for the nine months ended March 31, 2020 compared to $20,800 for the nine months ended March 31, 2019; an increase of $9,105 or 43.8%. Professional fees consist of accounting, audit and legal fees. The increase in fees in the current year is due to an increase in audit and accounting fees.

 

Payroll expense

Payroll expense was $52,551 for the nine months ended March 31, 2020 compared to $32,173 for the nine months ended March 31, 2019, an increase of $20,378 or 63.3%. The increase can be attributed to an increase of our administrative staff.

 

General & administrative expenses

General & administrative expenses (“G&A”) were $63,034 for the nine months ended March 31, 2020, compared to $64,262 for the nine months ended March 31, 2019; a decrease of $1,228 or 1.9%. In the current period our G&A expense was decreased when we recognized a credit of $38,484 for the prior period accrual for income tax. This decrease was offset by a $43,000 non-cash expense for stock compensation.

  

Other expense

Other expense for the nine months ended March 31, 2020 was $198,726. Other expense consisted of $21,226 of interest expense, and $62,500 of debt discount amortization and a $75,000 loss on the issuance of convertible debt as a result of the issuance of a new convertible promissory note. In addition, we had a $40,000 loss on the issuance of common stock when the Company granted 100,000 shares of common stock for services valued at $30,000. The shares were valued at $0.70, the closing stock price on the date of grant, for total non-cash expense of $70,000. $40,000 of which was recorded as a loss on the issuance of common stock.

 

For the three months ended March 31, 2019 we had $4,411 of interest expense.

 

  14  

 

 

Net Loss

Net loss for the nine months ended March 31, 2020 was $172,422 compared to net income of $89,166, after a $33,400 provision for income taxes, for the nine months ended March 31, 2019. The change from net income in the prior period to a net loss in the current period can be attributed to the loss of one of our larger customers as well as our non-cash expense for stock compensation and the issuance of a convertible note.

 

Liquidity and Capital Resources

 

As reflected in the accompanying financial statements, the Company has an accumulated deficit of only $203,004 at March 31, 2020, had a net loss of $172,422, and had net cash provided by operating activities of $42,366 for the nine months ended March 31, 2020. 

 

Net cash used in investing activities for the nine months ended March 31, 2020 and 2019 was $227,090 and $0, respectively, for the purchase of property and equipment.

 

Net cash received from financing activities for the nine months ended March 31, 2020 was $224,617 compared to $36,399 used by financing activities in the prior year.

 

The Company has established a line of credit with a commercial bank in the amount of $50,000. This is a revolving business line of credit (BLOC) and bears a fixed interest rate of 7%. The company has also established a corporate business credit card for use in travel related purposes. That line of credit is established at $20,000. The company has also established a renewable Bank Term Loan Facility in the approximate amount of $200,000 with a fixed interest rate of 5%.

 

Total consolidated revolving credit available under all credit arrangements is approximately $270,000. On March 9, 2018, the Company obtained a $180,000 loan against the bank term loan. The loan has a term of five years and required interest only payments of $600 until May 26, 2018, thereafter payments of principal and interest of $3,396.82. As of March 31, 2020, the balance on the loan is $116,857.

 

On February 28, 2018, the Company purchased certain real property and approximately 2 acres of land in Missouri. The total acquisition cost including all closing costs and fees was $256,443. The purchase price was partially financed with a $200,000 loan from the company’s primary bank. The loan has a term of 5-years, at an interest rate of 4.09% and requires monthly payments of interest and principal of $1,494.59 with a final payment of approximately $148,063 due March 1, 2023. As March 31, 2020, the balance on the loan is $178,985.

 

In September 2019 the Company purchased equipment to be used in their operations for a total acquisition price of $87,000. The equipment was purchased with a combination of cash and loan financing. The Company obtained a loan for $70,147. The loan, dated August 12, 2019, matures on August 12, 2024, bears interest at 6.6% per annum and requires monthly payments of interest and principal of $1,379.09. As of March 31, 2020 the balance on the loan is $63,117.

 

On December 18, 2019, the Company received a $38,000 loan disbursement from American Express. The loan bears interest at 8.98% per annum, is to be paid in full by December 23, 2022 and requires monthly payments of interest and principal of $1,208.23. As of March 31, 2020 the balance on the loan is $35,207.

 

On January 2, 2020, the Company executed a 10% convertible promissory note in which it agreed to borrow up to $300,000. The note is convertible at a price per share equal to the lower of (a) the Fixed Conversion Price (which is fixed at a price equal to $0.30); or (b) 80% of the lowest trading price of the Company’s common stock during the 5 consecutive trading days prior to the date on which lender elects to convert all or part of the Note. The initial deposit of $125,000 was made on January 15, 2020 and included a $25,000 OID. As required by ASC 470-20-30-6 the company recognized and measured the embedded beneficial conversion feature at the commitment date of $200,000 which was credited to paid in capital, a $150,000 debt discount and a $75,000 loss on the issuance of convertible debt. As of March 31, 2020, $62,500 of the debt discount has been amortized to interest expense.

 

  15  

 

 

On March 27, 2020, the Company received a $37,000 loan disbursement from American Express. The loan bears interest at 8.98% per annum, is to be paid in full by April 1, 2023 and requires monthly payments of interest and principal of $1,176.43. As of March 31, 2020 the balance on the loan is $37,000.

 

We believe that our principal difficulty in our inability to successfully implement our plan in full force and attain profits has been the lack of available capital to operate and expand our business. We believe that because our shareholders can’t deposit their shares and clear shares with certain broker dealers and clearing firms due to extreme FINRA and SEC regulatory burden, it has caused us to not be able to raise capital since we do not have an active trading market for our common stock.  As of the date of this filing we have no other commitment from any investor or investment-banking firm to provide us with the necessary funding and there can be no assurances we will obtain such funding in the future.  Failure to obtain this additional financing will have a material negative impact on our ability to generate profits in the future.

 

Critical Accounting Estimates and Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Note 1 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes.  Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

 

We are subject to various loss contingencies arising in the ordinary course of business.  We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies.  An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated.  We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

 

We recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities.  The deferred tax assets and liabilities represent the expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled.  Future tax benefits have been fully offset by a 100% valuation allowance as management is unable to determine that it is more likely than not that this deferred tax asset will be realized.

 

Off-Balance Sheet Arrangements 

 

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

 

Recent Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, they concluded that our disclosure controls and procedures were effective for the quarterly period ended March 31, 2020.

 

  16  

 

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.

 

Changes in Internal Controls

 

Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company's internal controls over financial reporting during the quarter ended March 31, 2020 that has materially affected, or is reasonably likely to materially affect, the Company's internal controls over financial reporting.

  

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

There are not presently any material pending legal proceedings to which the Company is a party or as to which any of our property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

ITEM 4. MINING SAFETY DISCLOSURES

 

Not applicable.

ITEM 5. OTHER INFORMATION.

 

None.

 

ITEM 6. EXHIBITS

 

Part I Exhibits

 

No. Description
31.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1 Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

 

Part II Exhibits

 

No. Description
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Label Linkbase Document
101.PRE XBRL Taxonomy Presentation Linkbase Document

 

  17  

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    Genesys Industries, Inc
     
    /s/ Shefali Vibhakar
    Ms. Shefali Vibhakar
    Chief Financial Officer, President and Treasurer
    (Principal Executive, Financial and Accounting Officer)
     
    May 15, 2020

  

  18